EU to use $2.7 billion fund to buy promising COVID-19 vaccines

BERLIN/BRUSSELS (Reuters) - The European Union is preparing to use an emergency 2.4-billion- euro ($2.7 billion) fund to make advance purchases of promising vaccines against the new coronavirus, EU officials told Reuters.The move was discussed at a meeting of EU ambassadors on Wednesday, after Germany, France, Italy and the Netherlands said they were speeding up negotiations with pharmaceutical companies to secure access to vaccines currently under development.The EU rainy-day fund, known as the..